Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTED: BioTrove Purchases Patent Portfolio from Genencor

CORRECTION: A September 29, 2003 GenomeWeb News article stated that BioTrove had licensed from Genencor International a portfolio of patents and patents and patent filings related to nanofluidic through-hole array technology. In fact, BioTrove purchased the portfolio of patents from Genencor.  GenomeWeb regrets the error. The corrected story is below.

 

NEW YORK, Sept. 29 (GenomeWeb News) - BioTrove said it has purchased from Genencor International a portfolio of patents and patent filings related to nanofluidic through-hole array technology.

 

BioTrove said that the intellectual property would bolster its existing through-hole array technology patent portfolio with new method and device claims.  BioTrove said that the technology is used in its Living Chip platform for molecular, cell, and tissue screening and storage.

 

Specific terms of the licensing deal were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.